Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model.
about
Hippocampal ER stress and learning deficits following repeated pyrethroid exposureEffects of developmental deltamethrin exposure on white adipose tissue gene expressionStudying permethrin exposure in flight attendants using a physiologically based pharmacokinetic modelA pharmacokinetic model of cis- and trans-permethrin disposition in rats and humans with aggregate exposure application.A physiologically based pharmacokinetic model of alvespimycin in mice and extrapolation to rats and humans.Mechanism of pyrethroid pesticide-induced apoptosis: role of calpain and the ER stress pathwayReconstructing organophosphorus pesticide doses using the reversed dosimetry approach in a simple physiologically-based pharmacokinetic modelUsing physiologically-based pharmacokinetic models to incorporate chemical and non-chemical stressors into cumulative risk assessment: a case study of pesticide exposuresAn update on computational oral absorption simulation.In vivo dermal absorption of pyrethroid pesticides in the rat.Tissue time course and bioavailability of the pyrethroid insecticide bifenthrin in the Long-Evans rat.Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling.Toxicokinetics of Deltamethrin: Dosage Dependency, Vehicle Effects, and Low-Dose Age-Equivalent Dosimetry in Rats.Lack of P-glycoprotein-mediated efflux and the potential involvement of an influx transport process contributing to the intestinal uptake of deltamethrin, cis-permethrin, and trans-permethrin.
P2860
Q28384794-4A96D6FA-F52D-424E-9FF8-FA90180B7F54Q28386680-450F7C7D-5A64-49A9-B38D-D7113B66C497Q33777528-5F0304FF-02A4-4855-BE29-D56AECC33453Q34292023-12340DCB-40C4-441B-BBC3-EA3E5E31E467Q34570770-D91DA2B5-B302-4194-9A96-77269B7A1FDDQ35161421-F8EE375D-EDC7-4489-B43C-326EA04C6D22Q35837860-B11B6EF1-C22C-4F9A-8092-3CD3496A27F8Q36067638-67D6408F-6B3A-48B7-803C-00DD43879E76Q37937047-B82EB61D-B85A-4E3D-AFB1-A83A0E01C7AAQ40053310-55AE5CD4-9096-406F-8C64-D5C352B507CDQ40542400-30F90B88-D821-47D7-A301-25BC2906E262Q42242976-DE04D485-1C06-4E2D-A8EA-1484E7D6BDDDQ47955238-F5AA7A97-50C2-4920-B43B-CF0ACD41F03FQ52760101-40BC070E-251D-44CA-A94B-9DFC3A7C7252
P2860
Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Physiologically based pharmaco ...... human diffusion-limited model.
@en
Physiologically based pharmaco ...... human diffusion-limited model.
@nl
type
label
Physiologically based pharmaco ...... human diffusion-limited model.
@en
Physiologically based pharmaco ...... human diffusion-limited model.
@nl
prefLabel
Physiologically based pharmaco ...... human diffusion-limited model.
@en
Physiologically based pharmaco ...... human diffusion-limited model.
@nl
P2093
P2860
P356
P1476
Physiologically based pharmaco ...... human diffusion-limited model
@en
P2093
David G Ross
Edward J Scollon
James M Starr
Michael F Hughes
R Woodrow Setzer
Rogelio Tornero-Velez
Rory B Conolly
Stephen J Godin
P2860
P304
P356
10.1093/TOXSCI/KFQ051
P577
2010-03-03T00:00:00Z